Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
出版年份 2019 全文链接
标题
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-23
DOI
10.1186/s13195-019-0550-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis
- (2019) Silvia Paciotti et al. CLINICA CHIMICA ACTA
- Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis
- (2019) Jean-Louis Bayart et al. JOURNAL OF NEUROLOGY
- Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration
- (2018) Isabel Santana et al. JOURNAL OF ALZHEIMERS DISEASE
- Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
- (2018) Inês Baldeiras et al. Alzheimers Research & Therapy
- Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes
- (2018) Armand Perret-Liaudet et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of xMAP and ELISA Assays for Detecting Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
- (2018) Li-San Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species
- (2018) Francisco Oliveira et al. NeuroImage-Clinical
- Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
- (2017) Christelle Gervaise-Henry et al. JOURNAL OF ALZHEIMERS DISEASE
- Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer’s disease patients
- (2017) António José Gabriel et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults
- (2017) Ge Li et al. Alzheimers Research & Therapy
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease
- (2017) Inês Baldeiras et al. JOURNAL OF ALZHEIMERS DISEASE
- Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry
- (2016) Josef Pannee et al. Alzheimers & Dementia
- Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
- (2016) Hugo Marcel Johan Vanderstichele et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
- (2016) Natalia Lelental et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- From innotest to the fully automated chemiluminescent b-amyloid(1-42) and total tau assays on the LUMIPULSE® G instrument series: Taking quantification of Alzheimer’s disease CSF biomarkers to the next level
- (2015) Sandra Pereson et al. Alzheimers & Dementia
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
- (2015) Maria João Leitão et al. Frontiers in Neurology
- AUTOMATION OF AMYLOID ELISAS BRINGS ALZHEIMER'S BIOMARKER STANDARDISATION ONE STEP FURTHER
- (2014) Britta Brix et al. Alzheimers & Dementia
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Biomarkers for Alzheimer's disease therapeutic trials
- (2010) Harald Hampel et al. PROGRESS IN NEUROBIOLOGY
- Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers
- (2009) Piotr Lewczuk et al. JOURNAL OF NEURAL TRANSMISSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started